Close
  Indian J Med Microbiol
 

Figure 3: Representative immunoblots of p-mTOR, total mTOR, p-p70S6K, total p70S6K, p-4E-BP1, and total 4E-BP1 (a). Effects of PLA, MCa, and PB supplementations on phosphorylation levels of p-mTOR/total mTOR (b), total mTOR/GAPDH (c), p-p70S6K/total p70S6K (d), total p70S6K/GAPDH (e), p-4E-BP1/total 4E-BP1 (f), and total 4E-BP1/GAPDH (g) in gastrocnemius muscle from Wistar rats. Values are presented as means ± SE of 4-5 animals.aP < 0.05 versus PLA 30 min;bP < 0.05 versus PLA 450 min;cP < 0.05 versus MCa 30 min;dP < 0.05 versus MCa 90 min;eP < 0.05 versus PB 30 min;fP < 0.05 versus PB 90 min andgP < 0.05 versus MCa 30 min (two-way analysis of variance, followed by a Holm-Sidak post-test). PLA: Placebo; MCa: Micellar casein; PB: Protein blend (MCa plus whey protein); mTOR: mechanistic target of rapamycin.

Figure 3: Representative immunoblots of p-mTOR, total mTOR, p-p70S6K, total p70S6K, p-4E-BP1, and total 4E-BP1 (a). Effects of PLA, MCa, and PB supplementations on phosphorylation levels of p-mTOR/total mTOR (b), total mTOR/GAPDH (c), p-p70S6K/total p70S6K (d), total p70S6K/GAPDH (e), p-4E-BP1/total 4E-BP1 (f), and total 4E-BP1/GAPDH (g) in gastrocnemius muscle from Wistar rats. Values are presented as means ± SE of 4-5 animals.<sup>a</sup><i>P</i> < 0.05 versus PLA 30 min;<sup>b</sup><i>P</i> < 0.05 versus PLA 450 min;<sup>c</sup><i>P</i> < 0.05 versus MCa 30 min;<sup>d</sup><i>P</i> < 0.05 versus MCa 90 min;<sup>e</sup><i>P</i> < 0.05 versus PB 30 min;<sup>f</sup><i>P</i> < 0.05 versus PB 90 min and<sup>g</sup><i>P</i> < 0.05 versus MCa 30 min (two-way analysis of variance, followed by a Holm-Sidak <i>post-test</i>). PLA: Placebo; MCa: Micellar casein; PB: Protein blend (MCa plus whey protein); mTOR: mechanistic target of rapamycin.